Department of Nuclear medicine, Sir Ganga Ram Hospital, Old Rajinder Nagar, New Delhi-110060
*Correspondence to: Department of Nuclear Medicine, Sir Ganga Ram Hospital, New Delhi-110060, Ph No. +91-11-25 9350544552, Fax No: 25861671, 25861696, E-mail: dr.anjalimittal@yahoo.co.in
Somatostatin receptors are over expressed in several neuroendocrine tumors making these receptors potential targets for radionuclide diagnosis and therapy. Indium-111 - DTPA octreotide is a somatostatin analog that has been used for detecting somatostatin receptor positive tumors for years. Somatostatin receptor scintigraphy and octreotide therapy have changed the management of neuroendocrine tumors. The object of this report is to highlight the role of radionuclide scintigraphy and therapy in neuroendocrine tumors.
Somatostatin, octreotide, somatostatin receptor scintigraphy
